Introduction
It has been established that Helicobacter pylori (H. pylori) induces mucosal inflammation or gastritis and subsequently major cellular and physiologic changes in the stomach (10) . In particular, H. pylori colonization of the stomach correlates with an increase in gastric G cells, gastrin expression and secretion (10) . Basal levels of acid secretion rise, presumably due to the elevated levels of circulating gastrin. It is assumed that the high gastric acid levels stimulate the production of somatostatin through putative chemoreceptors on the D cell. Once the D cell is activated, secreted somatostatin should inhibit the G cell by paracrine mechanisms (23) . Rather, what is observed in H. pyloriinfected patients are reduced numbers of D cells and somatostatin in the face of elevated gastrin production and acid secretion (12, 24) . To explain these findings, a direct inhibitory effect by inflammatory cytokines on D cells has been proposed (2, 3, 5) .
Evidence for the immunoregulation of somatostatin originates from in vitro studies demonstrating that cytokines such as TNFα and IL-8 inhibit somatostatin release from isolated rabbit and canine fundic D cells [(2, Beales, 1998 #6168)].
Gastrin null mice created by homologous recombination are hypochlorhydric (11, 13) . We have recently studied these mice in greater detail and have found that they also exhibit significant gastric mucosal inflammation caused by bacterial overgrowth as a consequence of reduced gastric acidity (30) . The present study extends these findings by measuring changes in tissue somatostatin and D cell numbers in gastrin null mice. As reviewed above, the levels of tissue somatostatin and the D cell numbers are quite relevant to understanding the regulation of gastric acid secretion. Thus, it is important to evaluate the reason for suppressed tissue somatostatin levels during gastritis. Our studies 5 in the gastrin-deficient and omeprazole-treated mice indicate that in the presence of gastritis, the stomach is stimulated to maximize acid output (30) . Thus, it is logical to propose that at the same time the stomach will act to suppress the inhibitors of gastric acid secretion. Since somatostatin is a major inhibitor of gastrin secretion and therefore acid secretion, we hypothesize that during inflammation somatostatin production is actively inhibited.
Analyzing the D cell population in the gastrin-deficient mice, we observed and report here that both D cells and somatostatin levels remain elevated despite significant gastritis. This raised the interesting possibility that gastrin may be the regulator of the D cell. We tested this hypothesis by infusing gastrin into the gastrin-deficient mice in the presence of antibiotics to resolve the inflammation. We found that the gastrin infusion suppressed both fundic and antral D cell populations and tissue somatostatin levels. We also examined changes in D cells in mice made hypergastrinemic by omeprazole.
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Material and Methods
Animals:
Gastrin deficient (G-/-) mice and strain-matched (C57Bl/6 x 129/Sv) wild type controls (G+/+) were bred by homozygous mating. G+/+ (n=10) and G-/-(n=12) mice were maintained in individual, sterile microisolator cages in non-barrier mouse rooms for 16 weeks. All mice were fasted overnight with access to water ad libitum before analysis. The study was performed with the approval of the University of Michigan Animal Care and Use Committee which maintains an American Association of Assessment and Accreditation of Laboratory Animal Care (AAALAC) facility.
Antibiotic treatment:
At 13 weeks of age G+/+ and G-/-were treated with antibiotics by adding 5 mg/kg of streptomycin to their drinking water for 3 weeks. At the same time, mice were given a subcutaneous injection of 100 mg/kg/day of cefoperazone (Sigma) (26). Each day their feces were collected, weighed, suspended in 1 ml PBS by vortexing, then diluted 1:100. One hundred microliters of the suspension were cultured on Luria broth plates and incubated at 37 o C for 24 hr. The colonies on each plate were counted and the results expressed as CFU/g feces. After 5 days of antibiotic treatment, the CFU/g feces decreased significantly from 300 x 10 3 CFU/g feces to 85 x 10 3 CFU/g feces. The bacterial count continued to decrease over the next 15 days of treatment (data not shown) and bacterial counts were undetected in mouse feces by day 20. Therefore we chose this duration for treatment. Mice were sacrificed after 20 days of antibiotic treatment and analyzed.
G-17 infusion:
G-/-mice were anaesthetized with xyalzine (20 mg/ml) and ketamine (100 mg/ml) at 8 weeks of age. A midline incision was made in the skin below the rib cage. Another incision was then made in the abdominal muscle directly under the cutaneous incision. The micro-osmotic pump (Alzet, model 1002), delivering 5µg/kg/hr of rat non-sulfated gastrin (G-17) (Bachem) was inserted into the peritoneal cavity. The muscle and skin incisions were then closed by silk sutures. Mice were continuously infused with G-17 for 14 days prior to sacrifice and analysis. Sections stained by H&E were graded on the intensity of inflammation and metaplasia by a pathologist blinded to the treatment and mouse genotypes according to
Eaton et al, a grading system developed for the histologic quantification of gastritis in mice (9) . A score of 0-1 was given to those sections showing no inflammation, 2 for gastritis (inflammatory infiltrate sufficient to displace glands and 3 for marked inflammation with metaplasia, where metaplasia is defined as the loss of normal fundic morphology with replacement of mucous-secreting glands (9) . The presence of metaplasia was confirmed by a PAS/alcian blue stain.
Blood collection:
After sacrifice, approximately 1 ml of blood was collected by cardiac puncture, aliquoted into tubes that were lithium heparinized and centrifuged at 15,000 rpm for 15 min at 4 o C. Plasma was collected immediately and stored at -20 o C until assayed.
Peptide extraction: Gastric sections were weighed and added to 500 µl of boiling double distilled water. After boiling for 5 min the biopsies were compressed using a glass rod, the tissue was boiled for an additional 5 min, then microfuged at 10,000 rpm for 15 min. The supernatant collected was designated as the water extract containing gastrin. The pellet was resuspended in 500 µl of boiling 3% acetic acid, boiled for 10 min and microfuged as above. The supernatant collected was the acid extract containing somatostatin. Extracts were stored at -20 o C until assayed by radioimmunoassay.
Somatostatin radioimmunoassay: Somatostatin concentrations in water and
acid biopsy extracts were measured using appropriate volumes and dilutions. Antiserum 11 1001 (CURE, UCLA) was used, which detects both somaotstatin-14 and somatostatin-28 (18) .
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I-Tyr-somatostatin-14 was used as the label and somatostatin-14 (50 pmol/L) was used to generate the standard curve. The ID 50 was 8 fmol/ml and the inter-and intraassay coefficients of variation were less than 5% and 12% respectively. was 1 fmol/ml and inter-and intra-assay coefficients of variation were less than 2% and 11% respectively.
Gastric acid concentrations:
The stomachs from G-/-mice infused with G-17 were opened along the greater curvature and washed with 2 ml normal saline (pH 7.0). All mice were fasted overnight before gastric samples were collected. The contents were centrifuged at 3,000 rpm for 5 min and the supernatant collected. The supernatant was titrated using 0.005N NaOH and gastric acidity was expressed in µEq.
Cell preparation and flow cytometry:
Lymphocytes and epithelial cells were isolated from the gastric mucosa according to a previous method (7) . Briefly, the stomach was dissected into 2 mm size pieces. The pieces were first incubated in 20 ml of 
Statistical analysis:
The results were statistically tested by unpaired t-test or one-way ANOVA as appropriate, using commercially available software (GraphPad Prism, GraphPad Software, San Diego, CA). A P<0.05 was considered significant.
Results
Mucosal inflammation in gastrin-deficient (G-/-) mice. We examined mucosal changes by histology and by flow cytometry to quantify T and B cell populations. Significant inflammation was observed in G-/- (Fig. 1B) compared to the G+/+ mice (Fig. 1A) . The histologic grades for all mice were scored by a pathologist blinded to the experiment. The mean histologic score for G-/-mice was 3.58 + 0.38 which was significantly greater than that of the G+/+ mice (0.75 + 0. (Fig. 2) .
However, the lymphocyte population after G-17 infusion did not return completely to baseline levels. Figure 3 illustrates the total number of bacterial counts in the G+/+ mice versus G-/-mice in both the fundus (Fig. 3A) and antrum (Fig. 3B) . After antibiotic treatment and G-17 infusion, there was a significant reduction in the total number of bacteria in both the fundus and antrum. However, these numbers were significantly greater than the bacterial counts for the G+/+ mice treated with antibiotics. Overall, the total number of bacteria in the antrum was significantly greater in the G-/-mice compared to the G+/+ animals.
G-17 infusion reduced bacterial overgrowth in the G-/-mice.
D cells and tissue somatostatin were suppressed after G-17 infusion.
To evaluate the response to inflammation, changes in D cells and tissue somatostatin concentrations were measured in G-/-mice. Immunohistochemical staining revealed positive anti-somatostatin antibodies in both the fundus and antrum of the G-/-mice ( Fig.   4A and B). These cells were quantified by morphometric analysis and showed that, after antibiotic treatment there was no change in the number of D cells in either the fundus or antrum (Fig. 5B) . In contrast to the antibiotic treatment, after G-17 infusion there was a reduction in the number of D cell staining in both the fundus and antrum ( Fig. 4C and D) .
After G-17 infusion, there was a significant decrease in D cell numbers in both fundic and antral regions of the stomach (Fig. 5B ). In addition, there was a significant reduction in both fundic and antral tissue somatostatin concentrations after G-17 infusion (Table 1) .
Thus, hypergastrinemia had a greater suppressive effect than inflammation on the D cell numbers and somatostatin levels. The decrease in somatostatin was consistent with an increase in circulating gastrin (558 + 114 pmol/l) in the G-/-mice infused with G-17 compared to resting levels in the G+/+ mice (54 + 8 pmol/l) ( Table 1 ). The reduction in somatostatin during G-17 infusion also correlated with an increase in gastric acidity.
Gastric acidity increased from 0.48 + 0.10 µEq in the untreated G-/-mice to 1.86 + 0.36 µEq in the G-17 infused mice. However, gastric acidity did not reach acid levels measured in the G+/+ mice (2.71 + 0.31 µEq) ( Table 1) . This result was similar to the incomplete recovery of acid secretion observed by Friis-Hansen et al (11) . There was no change in gastric acidity in G-/-mice after antibiotic treatment. Flow cytometry, which evaluated the total number of D cells in the epithelium correlated with the morphometric analysis (Fig. 5A ). Both morphometric and flow cytometric analyses revealed that there was a trend toward lower D cell numbers in the G-/-mice. This may reflect the modest inhibitory effect of inflammation on the D cell. Slightly fewer D cells were counted in the antrum compared to the fundus although there were 3-fold higher tissue somatostatin levels in the antrum compared to the fundus. Therefore, it appears that the concentration of somatostatin per cell is highest in the antrum. In addition, there was no significant difference in somatostatin concentrations between G+/+ and G-/-mice (Table 1) . (Table 2) , as reported in other animal models and human subjects (7). Histologic and flow cytometric evaluation revealed that G+/+ omeprazole-treated mice also showed significant inflammation (30) . After 2 months of omeprazole treatment, D cell numbers were significantly decreased in both the fundus and antrum compared to untreated animals ( Fig. 6B ). This correlated with a significant reduction in tissue somatostatin concentrations in both the fundus and antrum in the omeprazole-treated mice compared to controls ( Table 2) . After antibiotic treatment, the elevated circulating gastrin concentrations returned to resting levels (34 + 4 pmol/l). Subsequently, we found that resolution of the inflammation correlated with a return of tissue somatostatin levels (Table 2 ) and D cell numbers to baseline (Fig. 6B) . The flow cytometry was consistent with the morphometry (Fig. 6A) . The return of the D cells to baseline levels occurred in the presence of hypochlorhydria documented by acid concentrations of 1.62 + 0.59 µEq in omeprazole-treated mice compared to 5.62 + 0.70 µEq in untreated animals ( Table 2 ). Figure 7 illustrates the differences between the G-/-and omeprazole-treated mouse models. G+/+ mice treated with omeprazole become hypochlorhydric and thus are susceptible to bacterial overgrowth and inflammation. A consequence of the inflammation is the increase in plasma gastrin (30) (Fig. 7A ). When these mice were treated with antibiotics and the inflammation resolved, plasma gastrin concentrations normalized despite the stomach remaining hypochlorhydric (Fig. 7B , Table 2 ).
Hypergastrinemia in omeprazole-
Examining the fate of the D cell population, we found that D cell numbers were depressed in the hypergastrinemic state induced by omeprazole (G+/+ mice) (Fig. 6 ).
Certainly, this is as expected from prior studies suggesting that low acid levels inhibit the D cell (23) . However, we challenged this dogma by administering antibiotics to the omeprazole-treated mice to eliminate the inflammation-induced hypergastrinemia. With the reduction in plasma gastrin levels, the D cells returned to baseline resting levels despite persistent hypochlorydria (Fig. 7B, Table 2 ). Therefore, we concluded that D cells are regulated by fluctuations in gastrin and not gastric acid which did not change.
The results in the omeprazole model are supported by studies using G-/-mice. G-/-mice are hypochlorhydric due to a genetic deficiency of gastrin. These mice exhibit significant inflammation and increased G cell density (30) despite a lack of gastrin.
Since D cell numbers and somatostatin concentrations were unchanged even after antibiotic treatment, this lead us to propose that gastrin may be the critical factor required to suppress somatostatin production (Fig. 7C) . Confirming our suspicions, it was only after the infusion of G-17 into the gastrin null mice that we observed a reduction in somatostatin and D cell density (Fig. 7D) . Therefore, these results clearly show that hypergastrinemia is the major factor modulating the D cell during bacterial infection.
Discussion
We In wild type mice and human subjects, omeprazole induces significant hypergastrinemia presumably due to the decrease in gastric acid that in turn inhibits D cell secretion of somatostatin (14, 15) . Moreover, in the absence of somatostatin, inhibition of the G cell is removed allowing serum gastrin levels to rise (6, 21, 22) . Since we have shown that omeprazole treatment induces a gastritis and that the inflammation is a major activator of the G and parietal cell, our model demonstrates that G cell numbers should increase and serum gastrin levels should rise (30) . Indeed, this is what we observed and is also what has been observed in other models of chemical achlorhydria in rodents and in human subjects (4, 17, 28) . In these prior reports, modulation of the G and Although prior studies have indicated that gastrin stimulates somatostatin release, these studies were performed on isolated cell populations or in whole animals in the absence of inflammation, hypochlorhydria or bacterial overgrowth (8, 31 ). In addition, these studies examined the effect of acutely administering gastrin. Thus, we emphasize that the results shown here document an inhibitory effect of gastrin on somatostatin secretion in vivo when hypergastrinemia is induced by chronic inflammation. Since the studies were performed in vivo, it is not known under these conditions whether gastrin stimulates the 20 release of other ligands, e.g., HB-EGF, TGFα or trefoil proteins, or acts directly on the D cell (19, 20, 25, 27) . Certainly both possibilities may also occur in concert.
In summary, the findings reported here clearly show that hypergastrinemia, induced by inflammation, results in decreased D cell numbers. The stomach responds to the presence of inflammation by increasing gastric acidity, elevating G cell numbers and gastrin secretion that in turn stimulates parietal cells (30) . Coincident with the changes to increase acid secretion, hypergastrinemia also blocks the somatostatin inhibitory pathway (Fig. 8) . As a result, the stomach is able to maximize its gastric acid output in an attempt to clear bacterial infection. 
